Pharmacokinetics of metoclopramide in neonates

Journal of Clinical Pharmacology

Volumn 38, Issue 2, 1998, Pages 122-128

  Kearns, Gregory L ^a,e   Van Den Anker, John N ^b   Reed, Michael D ^c,d   Blumer, Jeffrey L ^c,d  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e CHILDREN S MERCY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METOCLOPRAMIDE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; DRUG HALF LIFE; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; INFANT; MALE; ONSET AGE; ORAL DRUG ADMINISTRATION; PREMATURITY;

EID: 0031882168     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1998.tb04400.x     Document Type: Article

References (29)

1. Herbst JJ: Gastroesophageal reflux. J Pediatr 1981;98:859-870.
2. Leung AKC, Lai PCW: Use of metoclopramide for the treatment of gastroesophageal reflux in infants and children. Curr Ther Res 1984;36:911-915.
3. Pettignano R, Chambliss CR, Darsey E, Heard M, Clark R: Cisa-pride-induced dysrhythmia in a pediatric patient receiving extracorporeal life support. Crit Care Med 1996;24:1268-1271.
4. Leeder JS, Kearns GL: Pharmacogenetics in pediatrics: implications for practice. Pediatr Clin North Am 1997;44:55-77.
5. Bateman DN: Clinical pharmacokinetics of metoclopramide. Clin Pharmacokinet 1983;8:523-529.
6. Harrington RA, Hamilton CW, Brogden RN, Linkewich JA, Ramankiewicz JA, Heel RC: Metoclopramide: an updated review of its pharmacological properties and clinical use. Drugs 1983; 25:451-494.
7. Bateman DN, Craft AW, Nicholson E, Pearson ADJ: Dystonic reactions and the pharmacokinetics of metoclopramide in children. Br J Clin Pharmacol 1983;15:557-559.
8. Kearns GL, Butler HL, Lane JK, Carchman SH, Wright GJ: Metoclopramide pharmacokinetics and pharmacodynamics in infants with gastroesophageal reflux. J Pediatr Gastroenterol Nutr 1988;7:823-829.
9. Sankaran K, Yeboah E, Bingham WT, Ninan A: Use of metoclopramide in preterm infants. Dev Pharmacol Ther 1982;5:114-119.
10. Shields BJ, MacKichan JJ: High performance liquid chromatographic method for the determination of metoclopramide in plasma. J Liq Chromatogr 1990;13:2643-2659.
11. Gomeni R, Gomeni C: AUTOMOD: a polyalgorithm for integrated analysis of linear pharmacokinetic models. Comput Biol Med 1979;9:38-48.
12. Marquardt DW: An algorithm for least-squares estimation of nonlinear parameters. J Soc Industrial Appl Math 1963;11:431-441.
13. Yamaoka K, Nakagawa T, Uno T: Application of Akaike's information criterion in the evaluation of linear pharmacokinetic equations. J Pharmacokinet Biopharm 1978;6:165-175.
14. Yamaoka K, Nakagawa T, Uno T: Statistical moments in pharmacokinetics. J Pharmacokinet Biopharm 1978;6:547-558.
15. Ross-Lee LM, Eadie MJ, Hooper WD. Bochner F: Single-dose pharmacokinetics of metoclopramide. Eur J Clin Pharmacol 1981;20:465-471.
16. Block W, Pingoud A, Khan M, Kjellerup P: The pharmacokinetics, bioequivalence and bioavailability of different formulations of metoclopramide in man. Arzneim Forschr 1981;31:1041-1045.
17. Danus O, Larrain F: The effects of metoclopramide on the pressure of the gastroesophageal sphincter in infants with gastric reflux. Rev Chil Pediatr 1974;45:396-397.
18. Meadow WL, Bui KC, Strates E, Dean R: Metoclopramide promotes feeding in preterm infants with feeding intolerance. Dev Pharmacol Ther 1989;13:38-45.
19. Leung AKC, Lai PCW: Use of metoclopramide for the treatment of gastroesophageal reflux in infants and children. Curr Ther Res 1984;36:911-915.
20. Hyman PE, Abrams CE, Dubois A: Gastric emptying in infants: response to metoclopramide depends on the underlying condition. J Pediatr Gastroenterol Nutr 1988;7:181-184.
21. Hyman PE, Abrams C. Dubois A: Effect of metoclopramide and bethanechol on gastric emptying in infants. Pediatr Res 1985;19:1029-1032.
22. Tolia V, Calhoun J, Kuhns L, Kauffman RE: Randomized, prospective double-blind trial of metoclopramide and placebo for gastroesophageal reflux in infants. J Pediatr 1989;115:141-145.
23. Machida HM, Forbes DA, Gall DG, Scott RB: Metoclopramide in gastroesophageal reflux of infancy. J Pediatr 1988;112:483-487.
24. Bellissant E, Duhamel JF, Guillot M, Pariente-Khayat A, Olive G, Pons G: The triangular test to assess the efficacy of metoclopramide in gastroesophageal reflux. Clin Pharmacol Ther 1997; 61:377-384.
25. Hyams JS, Leichtner AM, Zamett LO, Walters JK: Effect of metoclopramide on prolonged intraesophageal pH testing in infants with gastroesophageal reflux. J Pediatr Gastroenterol 1986; 5:716-720.
26. Pons G, Duhamel JF, Guillot M, Gouyoun JB, d'Athis P, Richard MO, et al: Dose response study of metoclopramide in gastroesophageal reflux in infancy. Fundam Clin Pharmacol 1993; 7:161-166.
27. Morselli PL: Clinical pharmacology of the perinatal period and early infancy. Clin Pharmacokinet 1989;17(suppl):13-28.
28. Miller RP, Roberts RJ, Fischer LF: Acetaminophen elimination kinetics in neonates, children and adults. Clin Pharmacol Ther 1976;19:284-294.
29. Weinshilboum RL, Raftogianis R, Wood T, Her C, van Loon J: Sulfotransferase molecular pharmacogenetics. In, Proceedings of the Third International Sulfation Workshop, Drymen, Scotland, September 22-25, 1996.